• EdU Imaging Kits (Cy3): Precision Cell Proliferation Analysi

  2026-06-13

  EdU Imaging Kits (Cy3) empower researchers to capture S-phase DNA synthesis with unmatched sensitivity, eliminating the limitations of BrdU assays. This guide demystifies experimental workflows, troubleshooting, and advanced applications tailored for robust cell proliferation and genotoxicity testing.

• Cucurbitacin I (JSI-124): Optimizing STAT3 Inhibition Workfl

  2026-06-12

  Cucurbitacin I (JSI-124) empowers researchers to dissect STAT3-dependent oncogenic processes with precision, enabling robust inhibition of tumor proliferation, migration, and resistance. This article spotlights best-practice protocols, troubleshooting strategies, and integration with advanced in vitro and in vivo models for cancer research.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301): P

  2026-06-12

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) address the need for high-specificity, rapid isolation of biotinylated molecules from complex mixtures in molecular biology and biochemical workflows. They are best applied in protein and nucleic acid purification, immunoprecipitation, and bioscreening where low non-specific binding is critical. They are not suited for applications requiring covalent target immobilization or for direct capture of non-biotinylated analytes.

• Tubastatin A: Next-Generation HDAC6 Inhibition for Myocardia

  2026-06-11

  Tubastatin A, a potent HDAC6 inhibitor, is reshaping research in cardiac injury, neuroprotection, and inflammation. Explore unique mechanistic insights, protocol guidance, and translational perspectives not found in prior reviews.

• Rotigotine: Dopamine D2/D3 Receptor Agonist in PD Research

  2026-06-11

  Rotigotine's robust profile as a dopamine D2/D3 receptor agonist empowers both cell-based and in vivo models of Parkinson's disease, offering superior neuroprotection and pathway modulation. Strategic workflow insights, protocol parameters, and troubleshooting guidance make this APExBIO compound an indispensable tool for translational neuroscience.

• Ceramides Promote Pro-viral Autophagy in Fish Nodavirus Infe

  2026-06-10

  This study leverages lipidomics to uncover how ceramide accumulation supports red-spotted grouper nervous necrosis virus (RGNNV) replication by promoting autophagy in infected fish cells. The findings clarify the molecular mechanisms of viral pathogenesis and highlight ceramide metabolism as a promising target for intervention in aquatic virology.

• Flumequine: Potent DNA Topoisomerase II Inhibitor for Resear

  2026-06-10

  Flumequine is a synthetic chemotherapeutic antibiotic that acts as a highly specific DNA topoisomerase II inhibitor. Its well-characterized mechanism, high purity, and robust performance make it valuable for DNA replication research and drug-response modeling. This article details evidence, practical considerations, and unique protocol parameters for Flumequine use.

• NHE1 in Macrophages Drives Octanal/Olfr2-Mediated Atheroscle

  2026-06-09

  This study reveals that sodium-hydrogen exchanger 1 (NHE1) in macrophages is a crucial downstream mediator of atherosclerosis progression driven by octanal-activated Olfr2. By elucidating the calcium-dependent pathway linking Olfr2 activation to NLRP3 inflammasome activation and inflammation, the research highlights NHE1 as a potential therapeutic target for cardiovascular disease.

• AMPK–SQSTM1/p62 Feedback Enhances Dual Antioxidant Activatio

  2026-06-09

  This study uncovers a double-positive feedback loop between AMPK and SQSTM1/p62 under metabolic stress, driving the synergistic activation of AMPK and NFE2L2/NRF2 antioxidant pathways. The findings provide mechanistic insight into tumor metabolic adaptation, especially in the context of STK11 and KEAP1 mutations, and highlight new potential intervention points for cancer research.

• α2-AR Agonist Hydrogel Reduces Osteosarcoma Recurrence via I

  2026-06-08

  This study demonstrates that α2-adrenergic receptor agonists, delivered through a thermo-sensitive hydrogel, can significantly reduce post-surgical osteosarcoma recurrence by enhancing immune-mediated tumor rejection. The findings establish a mechanistic link between α2-AR activation, T cell signaling, and improved clinical outcomes in osteosarcoma models.

• (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl) Urea: Redox & sE

  2026-06-08

  (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea (BPN-19186) is a fluorinated phenyl urea compound pivotal for redox pathway and sEH inhibition studies. Evidence supports its role in dissecting Nrf2 signaling and osteoclastogenesis, with robust solubility and validated purity ensuring reproducibility in advanced signaling pathway modulation research.

• BML-277: Potent Chk2 Inhibitor for DNA Damage Response Resea

  2026-06-07

  BML-277 is a potent and highly selective Chk2 inhibitor, offering nanomolar IC50 and Ki values. It enables precise modulation of the DNA damage checkpoint pathway and radioprotection of T-cells. This article details its mechanism, applications, and protocol best practices.

• ABCC10-Driven cGAMP Efflux Underlies Radiotherapy Resistance

  2026-06-06

  This study identifies ABCC10 as a novel transporter responsible for exporting 2'3'-cGAMP from cancer cells, thereby suppressing STING-mediated innate immune responses and contributing to radiotherapy resistance. These findings highlight ABCC10's potential as both a biomarker and therapeutic target for overcoming radioresistant tumors.

• Applied Protocols with Recombinant Human IL-15 in Immunology

  2026-06-05

  Recombinant Human IL-15 (E.coli, Tag Free, Lyophilized) from APExBIO empowers precise and reproducible T and NK cell activation workflows, supporting both classic immunology and emerging neuroimmune models. This article details stepwise protocols, troubleshooting strategies, and practical insights—bridging validated cell proliferation assays with translational research on immune modulation.

• Inflammatory Macrophage Niches Drive Kupffer Cell Plasticity

  2026-06-05

  This study uncovers how inflammatory changes in the hepatic microenvironment drive the phenotypic and functional reprogramming of Kupffer cells (KCs) during liver metastasis. By integrating advanced lineage-tracing and proliferation-recording models, the research delineates the dual mechanisms—monocyte-derived macrophage recruitment and KC plasticity—that replenish immunosuppressive macrophage populations, with implications for immunotherapy strategies.

15136 records 1/1010 page Next 12345 下5页 Last page